» Articles » PMID: 29372484

Comparative Impact of Systemic Delivery of Atorvastatin, Simvastatin, and Lovastatin on Bone Mineral Density of the Ovariectomized Rats

Overview
Journal Endocrine
Specialty Endocrinology
Date 2018 Jan 27
PMID 29372484
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: In addition to lipid-lowering properties, statins have been suggested to affect bone turnover by increasing the osteoblastic bone formation and blocking the osteoclastogenesis. However, there are many controversial reports regarding the beneficial effect of statins on osteoporosis. In this study, we investigated the therapeutic effects of the most important lipophilic statins administered orally for 60 days to the ovariectomized (OVX) female Sprague-Dawley rats and compared the effects on different harvested trabecular and compact bones.

Methods: Thirty female rats were divided into five equal groups including the normal rats, untreated OVX rats (negative control), and the OVX rats treated with atorvastatin (20 mg/kg/day), simvastatin (25 mg/kg/day), and lovastatin (20 mg/kg/day). The osteoporotic animals were treated daily for 60 days and euthanized at the end of experiments. The effectiveness of these treatments was evaluated by biomechanical testing, histopathologic, histomorphometric, micro-CT scan, real-time PCR, and serum biochemical analysis. Moreover, the hepatotoxicity and rhabdomyolysis related with these treatments were assessed by biochemistry analysis and histopathological evaluation.

Results: The results and statistical analysis showed that systemic delivery of simvastatin and lovastatin significantly increased serum calcium level, expression of osteogenic genes, bone mineral density (BMD), and biomechanical properties in comparison to the untreated OVX rats, especially in trabecular bones (P < 0.05). The results of different analysis also indicated that there was no statistical difference between the atorvastatin-treated animals and the negative control. Among all treatments, only atorvastatin showed an evident hepatotoxicity and myopathy.

Conclusions: It was concluded that the lovastatin and simvastatin efficiently ameliorated the OVX-induced osteoporosis. Moreover, the simvastatin-treated animals showed more resemblance to the normal group in terms of BMD, expression of osteogenic genes, serum biochemical parameters, histomorphometric findings, and biomechanical performance with no significant side-effects.

Citing Articles

In Vitro Release Dynamics of Atorvastatin-Loaded Alginate Particles for Enhanced Periodontal Treatment.

Hlawa I, Reske T, Chabanovska O, Scholz M, Vasudevan P, Oschatz S Polymers (Basel). 2025; 17(3).

PMID: 39940629 PMC: 11820141. DOI: 10.3390/polym17030427.


Combination treatment with whole body vibration and simvastatin improves the early osseointegration in aged rats.

Qiao Z, Gu M, Wang Y, Ma B, Pang S Bone Rep. 2024; 22:101790.

PMID: 39540057 PMC: 11558254. DOI: 10.1016/j.bonr.2024.101790.


Effect of local and systemic administration of atorvastatin for improving bone healing on critical defects.

Miranda-Filho F, Barbosa S, Panigali O, Silva M, Costa M, Flores F Braz Dent J. 2024; 35:e246114.

PMID: 39476113 PMC: 11506307. DOI: 10.1590/0103-6440202406114.


Physicochemical and Biological Characterization of Gelatin/Alginate Scaffolds Reinforced with -TCP, FDBA, and SrHA: Insights into Stem Cell Behavior and Osteogenic Differentiation.

Mohaghegh S, Nokhbatolfoghahaei H, Baniameri S, Farajpour H, Fakhr M, Shokrolahi F Int J Biomater. 2024; 2024:1365080.

PMID: 39376511 PMC: 11458296. DOI: 10.1155/2024/1365080.


The effects of simvastatin on the bone microstructure and mechanics of ovariectomized mice: a micro-CT and micro-finite element analysis study.

Liang Y, Yuan X, Dai X, Zhang G, Li C, Yang H BMC Musculoskelet Disord. 2024; 25(1):748.

PMID: 39294613 PMC: 11409800. DOI: 10.1186/s12891-024-07860-w.


References
1.
Mazziotti G, Bilezikian J, Canalis E, Cocchi D, Giustina A . New understanding and treatments for osteoporosis. Endocrine. 2011; 41(1):58-69. DOI: 10.1007/s12020-011-9570-2. View

2.
Chuengsamarn S, Rattanamongkoulgul S, Suwanwalaikorn S, Wattanasirichaigoon S, Kaufman L . Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia. Bone. 2010; 46(4):1011-5. DOI: 10.1016/j.bone.2009.12.023. View

3.
Kharode Y, Sharp M, Bodine P . Utility of the ovariectomized rat as a model for human osteoporosis in drug discovery. Methods Mol Biol. 2008; 455:111-24. DOI: 10.1007/978-1-59745-104-8_8. View

4.
Yamauchi M, Yamaguchi T, Nawata K, Tanaka K, Takaoka S, Sugimoto T . Increased low-density lipoprotein cholesterol level is associated with non-vertebral fractures in postmenopausal women. Endocrine. 2014; 48(1):279-86. DOI: 10.1007/s12020-014-0292-0. View

5.
Shah S, Werlang C, Kasper F, Mikos A . Novel applications of statins for bone regeneration. Natl Sci Rev. 2015; 2(1):85-99. PMC: 4630027. DOI: 10.1093/nsr/nwu028. View